Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.079;679;320;81;
%Companies according to biotechnology used: Genetic code;35;42;17;46;
%Companies according to biotechnology used: Functional units;44;48;41;27;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;26;31;16;26;
%Companies according to biotechnology used: Bioprocesses;49;40;75;29;
%Companies according to biotechnology used: Sub-cellular organisms;8;11;5;2;
%Companies according to biotechnology used: Bio-computing;23;32;8;5;
%Companies according to biotechnology used: Nanobiotechnology;15;20;7;2;
%Companies according to biotechnology used: Other;12;13;9;22;
Companies in which biotechnology activities are: Main and/or exclusive;519;436;72;11;
Companies in which biotechnology activities are: A secondary line of business;179;107;57;15;
Companies in which biotechnology activities are: A tool necessary for production;381;136;190;55;
%Company by field(s) of ultimate application of biotechnology use: Human Health;48;62;28;3;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;21;23;13;36;
%Company by field(s) of ultimate application of biotechnology use: Food products;33;25;51;33;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;22;19;18;58;
%Company by field(s) of ultimate application of biotechnology use: Environment;17;18;19;11;
%Company by field(s) of ultimate application of biotechnology use: Industry;15;17;13;3;
Personnel in R&D in biotechnology (no. of persons);9.795;6.459;2.590;745;
Personnel in R&D in biotechnology (no. of persons): Researchers;5.573;4.149;1.190;234;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;4.222;2.310;1.401;511;
Personnel in R&D in biotechnology (no. of persons): women;5.298;3.701;1.308;290;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;2.925;2.230;611;84;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;2.373;1.471;696;206;
Personnel in R&D in biotechnology (FTE);6.828,6;4.786,1;1.592,7;449,8;
Personnel in R&D in biotechnology (FTE): Researchers;4.106,5;3.140,9;811,9;153,7;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;2.722,1;1.645,2;780,8;296,2;
Personnel in R&D in biotechnology (FTE): women;3.811,7;2.728;883,7;200;
Personnel in R&D in biotechnology (FTE): (women) Researchers;2.190,7;1.684,7;447,7;58,4;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;1.621;1.043,4;436;141,6;
Internal expenditure on R&D (thousands of euros);533.826;357.195;150.471;26.160;
1) By nature of the expense: Current expenses;492.955;329.995;141.459;21.501;
1.1) Remuneration to researchers;203.439;144.769;51.775;6.895;
1.2) Remuneration to technicians and assistants;96.850;50.585;38.481;7.784;
1.3) Other current expenses;192.666;134.641;51.202;6.822;
2) By nature of the expense: Capital expenses;40.870;27.199;9.012;4.659;
2.1) Land and buildings;7.521;3.248;1.126;3.147;
2.2) Equipment and instruments;32.078;22.730;7.856;1.492;
2.3) Acquisition of specific R&D software;1.270;1.221;29;20;
1) By origin of the funds: National funds;432.869;285.287;122.831;24.752;
1.1) Own funds;319.046;179.647;116.254;23.144;
1.2) From companies;39.253;38.264;989;0;
1.3) Public Administration funds;70.063;62.869;5.587;1.607;
1.4) From Universities;156;156;0;0;
1.5) From non profit private institutions;4.351;4.351;0;0;
1) By origin of the funds: Foreign funds;100.956;71.908;27.640;1.409;
2.1) From EU programmes;20.070;18.776;886;408;
2.2) Other foreign funds;80.886;53.131;26.754;1.001;
Purchase of R&D services in biotechnology (thousands of euros);138.625;52.251;83.896;2.478;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;101.114;41.915;57.089;2.109;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;37.512;10.336;26.807;369;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;46;56;30;31;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;11;16;14;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;12;13;11;12;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;14;16;13;7;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;19;21;17;8;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;19;24;13;6;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;18;20;13;17;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;39;35;22;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;49;52;44;46;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;19;21;17;12;
% Companies that have requested biotechnology patents in Biotechnology;15;19;10;3;
Number of patents requested;466;338;101;27;
% Companies with income of an international origin related to biotechnological activities;24,9;27;23,8;11,9;
% Turnover representing income of an international origin related to biotechnological activities;0,9;4,5;0,8;1,1;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;71,3;51,6;76,3;24,5;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;28,7;48,4;23,7;75,5;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;92,2;55,4;99,5;92,4;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;2,4;14,1;0;4,1;
% Income of an international origin related with activities according to the classification: Operating source abroad;1,3;7;0,1;.;
% Income of an international origin related with activities according to the classification: Other;4,2;23,5;0,4;3,5;
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute